INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
Accounts Payable
INVO Bioscience Inc
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
INVO Bioscience Inc
NASDAQ:INVO
|
Accounts Payable
$2.3m
|
CAGR 3-Years
92%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$921m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$194.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is INVO Bioscience Inc's Accounts Payable?
Accounts Payable
2.3m
USD
Based on the financial report for Dec 31, 2023, INVO Bioscience Inc's Accounts Payable amounts to 2.3m USD.
What is INVO Bioscience Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
33%
Over the last year, the Accounts Payable growth was 73%. The average annual Accounts Payable growth rates for INVO Bioscience Inc have been 92% over the past three years , 33% over the past five years .